Clinical | Â | Â | Â | Â |
---|---|---|---|---|
endpoint | Variable | HR | 95% CI | P value * |
LMS | Age | 1.659 | 1.107 to 2.484 | 0.014 |
 | VCA-IgA | 1.518 | 1.012 to 2.277 | 0.043 |
 | Site of metastases 1 | 1.033 | 0.606 to 1.757 | 0.906 |
 | Number of metastases 2 | 1.585 | 1.013 to 2.481 | 0.044 |
 | Secondary metastases 3 | 3.132 | 1.948 to 5.036 | <0.001 |
OS | Age | 1.906 | 1.355 to 2.682 | <0.001 |
 | AJCC T classification | 1.530 | 1.074 to 2.177 | 0.018 |
 | AJCC N classification | 1.622 | 1.149 to 2.289 | 0.006 |
 | Site of metastases 1 | 1.464 | 1.023 to 2.095 | 0.037 |
 | Number of metastases 2 | 1.079 | 0.630 to 1.848 | 0.782 |
 | Secondary metastases 3 | 2.343 | 1.585 to 3.462 | <0.001 |
 | DFI | 5.050 | 3.356 to 7.576 | <0.001 |